El Kamel A[au] - Search Results

Year	Number of Results
1995	1
1996	3
1997	1
1999	3
2001	1
2002	2
2003	3
2004	5
2005	1
2006	3
2007	3
2008	2
2011	1
2012	4
2014	7
2015	7
2016	2
2017	6
2018	2
2019	1
2020	3
2021	8
2022	2

1

Biomaterial-Based Nanocomposite for Osteogenic Repurposing of Doxycycline.

El-Habashy S, Eltaher H, Gaballah A, Mehanna R, El-Kamel AH. El-Habashy S, et al. Among authors: el kamel ah. Int J Nanomedicine. 2021 Feb 12;16:1103-1126. doi: 10.2147/IJN.S298297. eCollection 2021. Int J Nanomedicine. 2021. PMID: 33603371 Free PMC article.

2

[Fight against tuberculosis in the world].

El Kamel A, Joobeur S, Skhiri N, Cheikh Mhamed S, Mribah H, Rouatbi N. El Kamel A, et al. Rev Pneumol Clin. 2015 Apr-Jun;71(2-3):181-7. doi: 10.1016/j.pneumo.2014.03.004. Epub 2014 May 28. Rev Pneumol Clin. 2015. PMID: 24878188 Review. French.

3

Hybrid bioactive hydroxyapatite/polycaprolactone nanoparticles for enhanced osteogenesis.

El-Habashy SE, Eltaher HM, Gaballah A, Zaki EI, Mehanna RA, El-Kamel AH. El-Habashy SE, et al. Among authors: el kamel ah. Mater Sci Eng C Mater Biol Appl. 2021 Feb;119:111599. doi: 10.1016/j.msec.2020.111599. Epub 2020 Oct 8. Mater Sci Eng C Mater Biol Appl. 2021. PMID: 33321643

4

Novel treatment strategies for brain tumors and metastases.

El-Habashy SE, Nazief AM, Adkins CE, Wen MM, El-Kamel AH, Hamdan AM, Hanafy AS, Terrell TO, Mohammad AS, Lockman PR, Nounou MI. El-Habashy SE, et al. Among authors: el kamel ah. Pharm Pat Anal. 2014 May;3(3):279-96. doi: 10.4155/ppa.14.19. Pharm Pat Anal. 2014. PMID: 24998288 Free PMC article. Review.

5

Modified Lipid Nanocapsules for Targeted Tanshinone IIA Delivery in Liver Fibrosis.

Ashour AA, El-Kamel AH, Abdelmonsif DA, Khalifa HM, Ramadan AA. Ashour AA, et al. Among authors: el kamel ah. Int J Nanomedicine. 2021 Dec 8;16:8013-8033. doi: 10.2147/IJN.S331690. eCollection 2021. Int J Nanomedicine. 2021. PMID: 34916792 Free PMC article.

6

[Pathophysiological features of COPD in obese patients].

El Kamel A, Joobeur S. El Kamel A, et al. Tunis Med. 2014 Jan;92(1):93-5. Tunis Med. 2014. PMID: 24879277 Free article. Review. French. No abstract available.

7

Enhanced oral permeability of Trans-Resveratrol using nanocochleates for boosting anticancer efficacy; in-vitro and ex-vivo appraisal.

El-Melegy MG, Eltaher HM, Gaballah A, El-Kamel AH. El-Melegy MG, et al. Among authors: el kamel ah. Eur J Pharm Biopharm. 2021 Nov;168:166-183. doi: 10.1016/j.ejpb.2021.08.020. Epub 2021 Sep 2. Eur J Pharm Biopharm. 2021. PMID: 34481049

8

Hyaluronic-Coated Albumin Nanoparticles for the Non-Invasive Delivery of Apatinib in Diabetic Retinopathy.

Radwan SE, El-Kamel A, Zaki EI, Burgalassi S, Zucchetti E, El-Moslemany RM. Radwan SE, et al. Among authors: el kamel a. Int J Nanomedicine. 2021 Jul 2;16:4481-4494. doi: 10.2147/IJN.S316564. eCollection 2021. Int J Nanomedicine. 2021. PMID: 34239300 Free PMC article.

9

Enhanced oral bioavailability of Tanshinone IIA using lipid nanocapsules: Formulation, in-vitro appraisal and pharmacokinetics.

Ashour AA, Ramadan AA, Abdelmonsif DA, El-Kamel AH. Ashour AA, et al. Among authors: el kamel ah. Int J Pharm. 2020 Aug 30;586:119598. doi: 10.1016/j.ijpharm.2020.119598. Epub 2020 Jul 3. Int J Pharm. 2020. PMID: 32629068

10

Lipid-Based Gliclazide Nanoparticles for Treatment of Diabetes: Formulation, Pharmacokinetics, Pharmacodynamics and Subacute Toxicity Study.

Nazief AM, Hassaan PS, Khalifa HM, Sokar MS, El-Kamel AH. Nazief AM, et al. Among authors: el kamel ah. Int J Nanomedicine. 2020 Feb 18;15:1129-1148. doi: 10.2147/IJN.S235290. eCollection 2020. Int J Nanomedicine. 2020. PMID: 32110012 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results